● Recruiting

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

Condition: Multiple Myeloma · Sponsor: Janssen Research & Development, LLC

PhasePhase 3

Planned participants1590

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

The purpose of this study is to compare the efficacy of teclistamab in combination with daratumumab and lenalidomide (Tec-DR) and talquetamab in combination with daratumumab and lenalidomide (Tal-DR) versus daratumumab, lenalidomide, dexamethasone (DRd).

This description comes directly from the study's public registry record.

Talk to the study team

Study Contact · 844-434-4210 · Participate-In-This-Study1@its.jnj.com

Always discuss trial participation with your own doctor first.

Locations (270)

Banner MD Anderson Cancer Center	Gilbert, Arizona, United States	Recruiting
University of Arizona Cancer Center	Tucson, Arizona, United States	Recruiting
UCSF Fresno	Clovis, California, United States	Recruiting
City of Hope Duarte	Duarte, California, United States	Recruiting
City of Hope Orange County Lennar Foundation Cancer Center	Irvine, California, United States	Recruiting
Cancer and Blood Specialty Clinic	Los Alamitos, California, United States	Recruiting
Valkyrie Clinical Trials	Los Angeles, California, United States	Recruiting
University of Connecticut	Farmington, Connecticut, United States	Recruiting
Yale New Haven Hospital	New Haven, Connecticut, United States	Recruiting
ChristianaCare Helen F Graham Cancer Center and Research Institute	Newark, Delaware, United States	Recruiting
Memorial Healthcare System	Hollywood, Florida, United States	Recruiting
AdventHealth Medical Group Blood & Marrow Transplant at Orlando	Orlando, Florida, United States	Recruiting

+ 258 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05552222